Shibuya chooses ADVA to deliver encrypted services to Nordic banks
16.2.2023 11:00:00 EET | Business Wire | Press release
ADVA (FSE: ADV) today announced that Shibuya is deploying its open optical technology to deliver secure managed services to leading banks across the Nordics and Baltics. The new network features robust optical encryption cards from Adva Network Security for critical data protection. Shibuya, a leading Swedish IT service provider and ADVA’s long-term Select partner, is using the solution to offer highly available connectivity with end-to-end data protection.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230215005611/en/
ADVA’s technology is helping banks securely transport mission-critical data throughout the Nordic and Baltic regions. (Photo: Business Wire)
“For our financial customers, security couldn’t be more crucial. That’s why we’re ensuring that our managed services protect data in motion with the most robust defense available. At Shibuya, we specialize in delivering secure and sustainable IT environments, and ADVA’s solutions are a perfect fit,” said Jessica Liljefors, business area manager at ShibuyaCare, Shibuya. “Adva Network Security‘s encryption technology and the unique experience of its team help us deliver the strongest possible protection and offer complete peace of mind to our banking clients and their customers. Combined with our extensive cybersecurity measures, local data centers near the customers and 24/7 IT support, we can provide the high-end services demanded by the financial sector.”
The new solution safeguards mission-critical financial traffic using ConnectGuard™ Optical encryption technology provided by Adva Network Security. The technology protects data in-flight to the strictest regulatory requirements with minimal impact on throughput. Part of the new infrastructure is built on the ADVA FSP 3000 TeraFlex™ platform, which uses ultra-flexible modulation with fractional QAM. This supports 600Gbit/s streams while ensuring the lowest possible cost per bit. ADVA’s technology also supports the latest generations of low-latency Fibre Channel, empowering financial network operators to keep up with the requirements of new server and storage technologies – a key consideration for Shibuya and some of its enterprise customers.
“The reputation of today’s financial institutions is built on trust and confidence. By enabling banking customers to harness our TeraFlex™ terminal and enterprise cards, Shibuya is ensuring that Nordic financial enterprises can protect the integrity of highly sensitive data wherever it happens to be in the network. What’s more, our technology delivers the highest levels of performance while also reducing cost per bit,” commented Hartmut Müller-Leitloff, SVP of sales EMEA at ADVA. “And for major banks, being able to utilize the best available storage area network protocols is also key for meeting new business continuity needs and staying operational in the face of any disruption.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
About Shibuya
Shibuya creates secure and sustainable IT environments for a digital Sweden. The company is one of the country’s premier operators in business-critical IT and delivers services in, among other things, data center infrastructure and IT operation, hybrid cloud solutions, cyber security, 24/7 IT service and support, communication, application operations and third-party services. Shibuya has strategic partnerships with leading manufacturers and reference solutions with several of the Nordics’ most demanding IT operations in both the private and public sectors. The company is certified according to ISO 14001, 9001 and 27001 standards and is part of the Pulsen Group. www.shibuya.se
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005611/en/
Contact information
For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release
Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
Cranium AI and ISTARI Forge Global Alliance to Drive Enterprise AI Security and Governance21.5.2026 13:00:00 EEST | Press release
Cranium AI, the leading end-to-end AI Security and Governance platform, and ISTARI, a leading cyber resilience advisory firm, today announced a strategic partnership to provide global organizations with an end-to-end AI security & governance solution. As organizations accelerate AI adoption, they face a critical challenge: implementing actionable, operational AI governance while keeping pace with the speed of the AI landscape. This collaboration bridges that gap by merging Cranium’s cutting-edge AI security and governance platform with ISTARI’s deep advisory expertise in cyber risk and operating model design. Together, the firms provide a powerful, end-to-end solution for enterprises navigating the complexities of AI transformation. A Unified Vision for Sustainable AI Governance The partnership is built on a shared mission to move organizations beyond fragmented AI initiatives toward fully operationalized, secure, and governed programs. By combining Cranium’s platform automation with I
Cognite and ABB Collaborate to Integrate Agentic AI into Industrial Applications to Deliver Faster Workflows21.5.2026 13:00:00 EEST | Press release
Cognite, the leader in Industrial AI, today announced a collaboration with ABB to assess how advanced industrial AI and data capabilities can be integrated to solve key use cases in the energy sector. By adding an agentic layer to established industrial applications, including ABB Ability™ SafetyInsight™ and ABB Ability™ AlarmInsight™, using the Cognite Industrial AI and Data platform, the collaboration aims to enable "agent-to-agent" orchestration. Leading energy producer Aker BP has signed on as the first customer to implement this new generation of intelligent offerings as part of its strategy to further increase its current production efficiency of 96% and achieve a production growth target of 525,000 barrels of oil equivalent per day by 2028. Transforming Data into Actionable Business Value By breaking down traditional data silos and shifting to outcome-based software orchestration, the collaboration aims to deliver significant business value to ABB and Cognite customers, includin
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts21.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malignancies and solid tumors have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (May 29–June 2, Chicago) and the 2026 European Hematology Association (EHA) Congress (June 11–14, Stockholm). Continuing to raise the bar in CLL At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell malignancies. The data emphasize impressive long-term outcomes, durability across patient populations, and a disciplined approach to advancing future regimens. Collectively, these data underscore BeOne’s strategy to lead in hematology science and patient impact by setting the standard today – while helping to shape the future of CLL. Amit Agarwal, M.D., Ph.D., Chief Medic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
